Inventor · disambiguated record
Jillian M. Prendergast
Also filed as: PRENDERGAST JILLIAN M
2 granted patents·16 pending applications·3 citations·filing 2015–2023
46Inventor score
Top patents by PatentIndex Score
18 records- 0183US11028181B2Glycan-interacting compounds and methods of useSEAGEN INC·Filed 2016·Granted Jun 8, 2021·3 cites·93 claims
- 0275US2024343834A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2023·Application pending·0 cites
- 0373US2023331868A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2023·Application pending·0 cites
- 0471US2024002537A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 0569US2024002422A1Glycan Analysis and ProfilingSEAGEN INC·Filed 2023·Application pending·0 cites
- 0669US2024000962A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2022·Application pending·0 cites
- 0768US2023312747A1Compositions and Methods for Treating CancerSEAGEN INC·Filed 2022·Application pending·0 cites
- 0867US2022259323A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2021·Application pending·0 cites
- 0965US2022057402A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2021·Application pending·0 cites
- 1065US2023001007A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2022·Application pending·0 cites
- 1165US2023029085A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 1260US2021011021A1Glycan-Interacting Compounds and Methods of UseSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 1358US11253609B2Glycan-interacting compounds and methods of useSEAGEN INC·Filed 2018·Granted Feb 22, 2022·0 cites·13 claims
- 1458US2021017213A1Glycan Analysis and ProfilingSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 1552US2020247902A1Compositions and methods for treating cancerSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 1652US2019031780A1Compositions and methods for targeting cancer stem cellsSIAMAB THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1746US2017305950A1Glycan analysis and profilingSIAMAB THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1842US2017306046A1Glycan-interacting compounds and methods of useSIAMAB THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jillian M. Prendergast files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →